AMNIODERM+ Medical Device Clinical Study

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

November 16, 2022

Primary Completion Date

March 30, 2023

Study Completion Date

March 30, 2023

Conditions
Non-healing WoundDiabetic Foot
Interventions
DEVICE

AMNIODERM+

"A common surgical approach in chronic wound treatment aims at the promotion of epithelization by a combination of debridement manipulations (removal of non-vital tissues) and infection/inflammation management using antibacterial wound dressings (antibiotics or silver covering). The advantages of biomaterials can be attributed to their unique mechanical, immunological, and regenerative properties.~The product will be evaluated in the subjects not responding to SoC."

Trial Locations (1)

Unknown

Národní Endokrinologický a Diabetologický ústav, Ľubochňa

All Listed Sponsors
lead

BioHealing s.r.o.

INDUSTRY